Released Feb 22, 2024, after the close
10-K filed Feb 22, 2024, 53 days after period end · 0001636422-24-000016
Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$75.08M$75.08M derived+8.6% vs Q4 2022+1.8% vs Q3 2023
Net Income-$30.31M-$30.31M derivedN/M vs Q4 2022N/M vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$32,785,000N/M
Operating Cash Flowderived-$19,041,000N/M
Free Cash Flowderived-$19,296,000N/M
Margins · derived
Operating margin-43.7%+9.5 pt vs Q4 2022
Net margin-40.4%+11.4 pt vs Q4 2022
What the release said
The release
Same quarter
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $75.08M | $69.16M | $64.72M | $53.28M |
| Net Income | -$30.31M | -$35.78M | -$48.99M | -$43.02M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR